|
CN112063625A
|
|
Nucleic acid encoding ARL2BP and uses thereof
|
|
CN112029773A
|
|
Nucleic acids encoding BDNF and uses thereof
|
|
CN111926015A
|
|
Oligonucleotide, viral vector and application thereof and RNAi pharmaceutical preparation
|
|
CN111944813A
|
|
Nucleotide, viral vector and application thereof, and RNAi pharmaceutical preparation
|
|
CN111944814A
|
|
Oligonucleotide, viral vector and application thereof and RNAi pharmaceutical preparation
|
|
CN111826378A
|
|
Nucleotide sequence for coding human receptor tyrosine kinase Mer and application thereof
|
|
CN111849991A
|
|
Oligonucleotide and application thereof
|
|
CN111849998A
|
|
Nucleic acid molecule for coding human vitellogenin 1 and application thereof
|
|
CN111926021A
|
|
Recombinant human norrin cystine knot growth factor expression vector and application thereof
|
|
CN111909935A
|
|
Expression vector of recombinant human frizzled receptor 4(FZD4) and application thereof
|
|
CN111876415A
|
|
Use of RNAi agents in the prevention or treatment of coronavirus infection
|
|
CN111850043A
|
|
ECEL1 recombinant adeno-associated virus vector and application
|
|
CN111705069A
|
|
Multi-neurotrophic factor combined expression vector and application thereof
|
|
CN112111519A
|
|
ND4 gene recombinant adeno-associated virus vector and preparation method and application thereof
|
|
CN112111518A
|
|
ND4 gene recombinant adeno-associated virus vector and preparation method and application thereof
|
|
CN112111517A
|
|
ND4 gene recombinant adeno-associated virus vector and preparation method and application thereof
|
|
CN112111515A
|
|
ND4 gene recombinant adeno-associated virus vector and preparation method and application thereof
|
|
CN111621502A
|
|
Coding sequence of retinal cleavage protein, construction of expression vector thereof and application thereof
|
|
CN111518813A
|
|
Coding sequence of rhodopsin, construction of expression vector thereof and application thereof
|
|
CN111068071A
|
|
Gene therapy for Leber genetic optic neuropathy
|
